{
  "ticker": "BIIB",
  "year": 2022,
  "quarter": 4,
  "last_updated": "2025-04-15T15:30:14.989776",
  "count": 20,
  "transactions": [
    {
      "id": 25077,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2022-12-08",
      "transaction_shares": "350",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2367.7483"
    },
    {
      "id": 47975,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2022-12-08",
      "transaction_shares": "350",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2367.7483"
    },
    {
      "id": 82703,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2022-12-08",
      "transaction_shares": "350",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2367.7483"
    },
    {
      "id": 125528,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Kramer Robin",
      "reporting_owner_cik": "0001609222",
      "reporting_owner_position": "Chief Accounting Officer",
      "transaction_date": "2022-12-08",
      "transaction_shares": "350",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2367.7483"
    },
    {
      "id": 25082,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2022-12-02",
      "transaction_shares": "131",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2807.2903"
    },
    {
      "id": 25084,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Alzheimer's Disease",
      "transaction_date": "2022-12-02",
      "transaction_shares": "1285",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "3395"
    },
    {
      "id": 47987,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2022-12-02",
      "transaction_shares": "131",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2807.2903"
    },
    {
      "id": 47990,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Alzheimer's Disease",
      "transaction_date": "2022-12-02",
      "transaction_shares": "1285",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "3395"
    },
    {
      "id": 82718,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2022-12-02",
      "transaction_shares": "131",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2807.2903"
    },
    {
      "id": 82721,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Alzheimer's Disease",
      "transaction_date": "2022-12-02",
      "transaction_shares": "1285",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "3395"
    },
    {
      "id": 125544,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Murphy Nicole",
      "reporting_owner_cik": "0001910644",
      "reporting_owner_position": "Head of Pharm Ops and Tech",
      "transaction_date": "2022-12-02",
      "transaction_shares": "131",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "2807.2903"
    },
    {
      "id": 125547,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Izzar Rachid",
      "reporting_owner_cik": "0001875506",
      "reporting_owner_position": "Head of Alzheimer's Disease",
      "transaction_date": "2022-12-02",
      "transaction_shares": "1285",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "3395"
    },
    {
      "id": 25085,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2022-11-14",
      "transaction_shares": "5610",
      "transaction_price": "300.11",
      "transaction_type": "S",
      "shares_after_transaction": "5711.0168"
    },
    {
      "id": 47992,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2022-11-14",
      "transaction_shares": "5610",
      "transaction_price": "300.11",
      "transaction_type": "S",
      "shares_after_transaction": "5711.0168"
    },
    {
      "id": 82723,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2022-11-14",
      "transaction_shares": "5610",
      "transaction_price": "300.11",
      "transaction_type": "S",
      "shares_after_transaction": "5711.0168"
    },
    {
      "id": 125549,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "Gregory Ginger",
      "reporting_owner_cik": "0001545716",
      "reporting_owner_position": "EVP, Human Resources",
      "transaction_date": "2022-11-14",
      "transaction_shares": "5610",
      "transaction_price": "300.11",
      "transaction_type": "S",
      "shares_after_transaction": "5711.0168"
    },
    {
      "id": 25072,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Off & Corp Sec",
      "transaction_date": "2022-10-27",
      "transaction_shares": "5532",
      "transaction_price": "280.70",
      "transaction_type": "S",
      "shares_after_transaction": "39396"
    },
    {
      "id": 47963,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Off & Corp Sec",
      "transaction_date": "2022-10-27",
      "transaction_shares": "5532",
      "transaction_price": "280.70",
      "transaction_type": "S",
      "shares_after_transaction": "39396"
    },
    {
      "id": 82687,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Off & Corp Sec",
      "transaction_date": "2022-10-27",
      "transaction_shares": "5532",
      "transaction_price": "280.70",
      "transaction_type": "S",
      "shares_after_transaction": "39396"
    },
    {
      "id": 125511,
      "issuer_name": "BIOGEN INC.",
      "reporting_owner": "ALEXANDER SUSAN H",
      "reporting_owner_cik": "0001263839",
      "reporting_owner_position": "EVP Chief Legal Off & Corp Sec",
      "transaction_date": "2022-10-27",
      "transaction_shares": "5532",
      "transaction_price": "280.70",
      "transaction_type": "S",
      "shares_after_transaction": "39396"
    }
  ]
}